AMLODIPINE
Identification of Amlodipine
| No description |
Google image searchProduct monograph
Active ingredient
amlodipine (amlodipine besylate), 2.5 MG
DIN: 02492199
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 18-SEP-2023
ATC:
- C08 — CALCIUM CHANNEL BLOCKERS (ATC, ATC/DDD, )
- C08C — SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS (ATC, ATC/DDD)
- C08CA — Dihydropyridine derivatives (ATC, ATC/DDD)
- C08CA01 — AMLODIPINE (ATC/DDD)
Reference brand drug: Norvasc
Pharmaceutical standard: MFR
